Priyam Singh

Title: Priyam Singh: Innovator in Retinitis Pigmentosa Treatment

Introduction

Priyam Singh is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical research, particularly in the treatment of retinitis pigmentosa (RP). With a total of 3 patents to his name, Singh is dedicated to advancing therapeutic options for individuals affected by this condition.

Latest Patents

Singh's latest patents focus on allele-specific modulators of P23H rhodopsin. These embodiments provide methods, compounds, and compositions aimed at treating, preventing, ameliorating, or slowing the progression of retinitis pigmentosa, including autosomal dominant retinitis pigmentosa (AdRP). The inventions involve administering a P23H rhodopsin specific inhibitor to a subject. The allele-specific antisense compounds are designed to selectively inhibit the expression of the P23H rhodopsin mutant protein more effectively than the wild-type protein. This selective inhibition allows the normal protein produced from the wild-type allele to maintain rod survival and function in affected individuals.

Career Highlights

Throughout his career, Priyam Singh has focused on innovative solutions for genetic disorders. His work has garnered attention in the scientific community, contributing to a better understanding of how to manage and treat retinitis pigmentosa. His dedication to research and development has positioned him as a key figure in this area of study.

Collaborations

Singh has collaborated with esteemed colleagues, including Susan F. Murray and Punit P. Seth. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Priyam Singh's contributions to the field of retinitis pigmentosa treatment exemplify his commitment to innovation and improving patient outcomes. His work continues to inspire advancements in medical research and therapeutic development.